Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review
This systematic review synthesises evidence on the emergence of antimicrobial resistance after mass azithromycin distribution.
MDA
Fiche de référence des doses de Zithromax recommandées
Dosages de Zithromax en poudre pour suspension buvable et en comprimés. en fonction de la taille et de l'âge
Folha de referencia das directrizes para a dosagem do Zitromax
Dosagem dos comprimidos e suspensão oral em pó (SOP) de Zithromax Baseada na Altura e Idade Julho de 2018
Hoja de referencia de guía para la dosificación de Zithromax
Dosificación de Zithromax polvos para suspensión oral (PSO) y tabletas basada en talla y peso Julio de 2018
Zithromax dosing guidance reference sheet
Height and age-based dosing for Zithromax POS and tablets as at July 2018
An impact evaluation of two rounds of mass drug administration on the prevalence of active trachoma: A clustered cross sectional survey
This study investigated the impact of two round of mass drug administration on trachoma prevalence in Plateau and Nasarawa States of Nigeria.
Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters
This study assesses whether mass azithromycin distributions could be discontinued after 4 years of treatment in communities with severe trachoma in northern Ethiopia.
Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study
This study was conducted to assess the coverage of azithromycin mass treatment and its determinants in Awi Zone, Northwestern Ethiopia.
One round of azithromycin MDA adequate to interrupt transmission in districts with prevalence of trachomatous inflammation—follicular of 5.0-9.9%: Evidence from Malawi
The study demonstrates that in Malawi districts with TF of 5.0–9.9%, one round of azithromycin MDA with 80% coverage associates with a reduction in TF prevalence to <5%.
Azithromycin to reduce childhood mortality in Sub-Saharan Africa
This study hypothesized that mass distribution of a broad-spectrum antibiotic agent to preschool children would reduce mortality in areas of sub-Saharan Africa
